Docetaxel as Salvage Therapy in Highly Pretreated and Drug Resistant Gastrointestinal Carcinomas

Clinical medicine. Oncology
doi 10.4137/cmo.s919
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Salvage Therapy for Castration-Refractory Prostate Cancer Resistant to Docetaxel

Japanese Journal of Urology
Urology
2013English

Use of Letermovir as Salvage Therapy for Drug-Resistant CMV Retinitis: A Case Series

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Bevacizumab Monotherapy as Salvage Therapy for Advanced Clear Cell Renal Cell Carcinoma Pretreated With Targeted Drugs

Clinical Genitourinary Cancer
OncologyUrology
2016English

Radioembolization as a Salvage Therapy for Heavily Pretreated Patients With Colorectal Cancer Liver Metastases: Factors That Affect Outcomes

Clinical Colorectal Cancer
OncologyGastroenterology
2015English

Advances in Drug Therapy of Gastrointestinal Ulceration

Gut
Gastroenterology
1990English

Salvage T Cell Therapy for Therapy Resistant Viral Diseases After Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

Dasatinib as Salvage Therapy for Steroid Refractory and Imatinib Resistant or Intolerant Sclerotic Chronic Graft-Versus-Host Disease

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

Docetaxel Monotherapy as Second-Line Treatment for Pretreated Advanced Non-Small Cell Lung Cancer Patients

Korean Journal of Internal Medicine
Internal Medicine
2007English

Tumor-Targeting, pH-sensitive Nanoparticles for Docetaxel Delivery to Drug-Resistant Cancer Cells

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy